THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)

Clinical trials for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) explained in plain language.

Never miss a new study

Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) trials appear

Sign up with your email to follow new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

New therapy offers hope for controlling rare, Life-Threatening blood disorder

Disease control Completed

This study tested a new medicine called BAX 930 for people born with a severe, inherited blood clotting disorder called congenital TTP. The goal was to see if BAX 930, which replaces a missing enzyme, could prevent or treat dangerous clotting events better than the standard treat…

Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)

Phase: PHASE3 • Sponsor: Baxalta now part of Shire • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)

Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) trials appear

New therapy offers hope for controlling rare, Life-Threatening blood disorder